Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Indonesia’s e-commerce market to surpass $46 billion in 2025, forecasts GlobalData

Indonesia’s e-commerce market is witnessing rapid growth, driven by rising internet penetration, smartphone usage, and a growing middle class. Online shopping festivals, payment innovations, and mobile wallet adoption are fueling consumer demand. Government efforts to boost digital infrastructure and transaction security are further accelerating the shift. Against this backdrop, the market is projected to reach […]
Read more

Daytona 500 generates estimated $388.2 million in sponsorship revenue for 2025, reveals GlobalData

The Daytona 500’s premier annual sponsorship agreement is with Goodyear, the tire manufacturer, which has renewed its commitment to sponsor NASCAR. The partnership designates Goodyear as the official tire provider for NASCAR’s top three national series, including the NASCAR Cup Series. Valued at an estimated $125 million over five years, the deal underscores Goodyear’s longstanding […]
Read more

Remegen eyes competitive DMT market as telitacicept shows promise in gMG, says GlobalData

At the recently held 2025 American Academy of Neurology (AAN) meeting, Remegen presented positive Phase III results for telitacicept in patients with AChR+ or MuSK+ generalized myasthenia gravis (gMG). The B cell-targeting therapy demonstrated a favorable efficacy and safety profile over 24 weeks, showing clinically meaningful improvement. These findings position telitacicept as a potential challenger […]
Read more

Australia mammography equipment market poised for 7% CAGR through 2034, forecasts GlobalData

Australia’s breast cancer screening landscape is evolving, with innovation in imaging and complementary diagnostics driving a shift toward more personalized care. While mammography remains the cornerstone, new technologies such as lipid-based blood tests are improving detection in patients with dense breast tissue. This progress is expected to fuel steady growth in the mammography equipment market, […]
Read more

OX40 inhibitors may transform atopic dermatitis landscape, says GlobalData

The atopic dermatitis (AD) treatment landscape is witnessing intensified competition with several novel therapies nearing market entry. While biologics like dupilumab have already transformed care, emerging drug classes such as OX40 inhibitors are showing promise in clinical trials. Their potential for long-lasting efficacy and favorable safety profiles may significantly advance treatment options for moderate-to-severe AD […]
Read more

Trump’s tariff U-turn drives 550% surge in influencer debate amid deep divide, finds GlobalData

President Donald Trump hit a 90-day pause on tariffs for key US trade partners, except China. The unexpected move reversed his hardline stance, triggered a market rally, and eased global trade tensions. Consequently, the conversation related to ‘Tariffs’ among the influencers week-on-week surged by 550%, in the second week of April, reveals the Social Media […]
Read more

US tariffs trigger strategic shift in global enterprise tech investments and AI talent dynamics, says GlobalData

The US tariffs introduced under the Trump administration are prompting enterprise technology firms to rethink their strategies amid rising costs and economic uncertainty. Beyond immediate IT budget pressures, these policy shifts are driving changes in supply chains, vendor diversification, and sourcing models, ultimately reshaping global tech investments and intensifying challenges around AI talent mobility and […]
Read more

Axsome Therapeutics’ AXS-05 challenges current standard of care as promising non-antipsychotic for Alzheimer’s agitation, says GlobalData

At the recently held American Academy of Neurology (AAN) 2025 annual meeting, Axsome Therapeutics presented promising data for AXS-05 (bupropion + dextromethorphan) in treating agitation associated with Alzheimer’s disease (AD). With a novel, non-antipsychotic mechanism and a favorable safety profile, AXS-05 addresses a critical unmet need in managing distressing behavioral symptoms, potentially reshaping the current […]
Read more

India and Japan offer hope amid 6% decline in global deal activity in Q1 2025, reveals GlobalData

The global deal landscape (mergers & acquisitions (M&A), private equity and venture financing deals) declined 6% year-on-year (YoY) during the first quarter (Q1) of 2025, as economic uncertainty weighed on investor confidence. However, markets like India and Japan stood out by defying the global trend, signaling that select regions continue to attract deal-makers despite broader […]
Read more

DHTs promise detection of disease progression in early PD patients receiving symptomatic treatment, says GlobalData

At the recently held AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases, Roche outlined the effectiveness of digital health technologies (DHTs) in providing more sensitive measures of disease progression in early Parkinson’s disease (PD). There are no pathological or imaging-based biomarkers to measure a PD patient’s progression. Instead, physicians rely on clinical examinations and […]
Read more

Large pharma drug licensing from China reaches record high at 28% in 2024, reveals GlobalData

Licensing agreements for Chinese drug candidates hit a record high in 2024, with large pharma in-licensing 28% of innovator drugs from Chinese biopharma companies. Total deal values of innovator drug licensing agreements involving Chinese biopharma licensors surged 66%, from $16.6 billion in 2023 to $41.5 billion in 2024, marking a five-year high, according to GlobalData, […]
Read more
1 … 72 73 74 75 76 … 774